title: Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin.
abstract: Strongyloides stercoralis affects over 100 million people worldwide. Those people most susceptible to infection are those with an immunocompromising condition, such as cancer or human immunodeficiency virus (HIV). Local disease may spread throughout the body of the host, causing a condition termed disseminated strongyloidiasis. Standard treatment for Strongyloides stercoralis infection is oral ivermectin. We describe a patient with chronic lymphocytic leukemia diagnosed with disseminated strongyloidiasis two weeks after initial presentation. After repeated dosing of oral ivermectin with no clinical response, serum and cerebral spinal fluid (CSF) concentrations of ivermectin were measured to assess absorption. The peak serum concentration of 49.3 ng/mL correlated with a CSF concentration of 0.14 ng/mL. Despite these concentrations, the patient eventually succumbed to multi-system organ failure. We discuss the reasons for treatment failure and explore the utility of measuring ivermectin concentrations.
authors.affiliation: Lexington Infectious Disease Consultants, Lexington, KY 40503, USA.
authors.forename: Charles E
authors.initials: CE
authors.lastname: Rose
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Paciullo
authors.forename: David R
authors.initials: DR
authors.lastname: Kelly
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Dougherty
authors.forename: Lawrence L
authors.initials: LL
authors.lastname: Fleckenstein
references.citation: Clin Infect Dis. 2001 Oct 1;33(7):1040-7
references.pmid: 11528578
references.citation: Am J Trop Med Hyg. 1996 Nov;55(5):477-81
references.pmid: 8940976
references.citation: Am J Trop Med Hyg. 1987 Jul;37(1):157-61
references.pmid: 3605497
references.citation: Rev Infect Dis. 1981 May-Jun;3(3):397-407
references.pmid: 7025145
references.citation: N Engl J Med. 1966 Nov 17;275(20):1093-6
references.pmid: 5925209
references.citation: Am J Med. 1973 Dec;55(6):832-8
references.pmid: 4800567
references.citation: Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):702-3
references.pmid: 9015524
references.citation: Lancet. 2000 Jan 1;355(9197):43-4
references.pmid: 10615895
references.citation: J Pharm Biomed Anal. 2006 Mar 3;40(4):1013-20
references.pmid: 16242280
references.citation: Infection. 2005 Oct;33(5-6):383-6
references.pmid: 16258873
references.citation: Am J Trop Med Hyg. 1999 Jan;60(1):146-9
references.pmid: 9988339
references.citation: Clin Infect Dis. 2000 Sep;31(3):E5-6
references.pmid: 11017858
references.citation: J Clin Pharmacol. 2002 Oct;42(10):1122-33
references.pmid: 12362927
references.citation: Clin Infect Dis. 1993 Nov;17(5):900-2
references.pmid: 8286637
references.citation: Am J Trop Med Hyg. 2005 Nov;73(5):911-4
references.pmid: 16282302
references.citation: Am J Epidemiol. 1990 Aug;132(2):257-64
references.pmid: 2196791
references.citation: Am J Trop Med Hyg. 2005 Jul;73(1):122-4
references.pmid: 16014846
references.citation: Curr Opin Infect Dis. 2006 Dec;19(6):588-93
references.pmid: 17075336
references.citation: Clin Microbiol Rev. 2004 Jan;17(1):208-17
references.pmid: 14726461
references.citation: Am J Trop Med Hyg. 1998 Oct;59(4):535-8
references.pmid: 9790425
references.citation: Intern Med. 2000 Sep;39(9):695-700
references.pmid: 10969899
references.citation: Ann Pharmacother. 2007 Dec;41(12):1992-2001
references.pmid: 17940124
references.citation: Clin Infect Dis. 2005 Apr 1;40(7):1005-15
references.pmid: 15824993
references.citation: Adv Parasitol. 1999;42:277-341
references.pmid: 10050275
references.citation: Clin Infect Dis. 2005 Jul 1;41(1):e5-8
references.pmid: 15937753